These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30060970)

  • 1. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
    Wilson TG; d'Udekem Y; Winlaw DS; Cordina RL; Celermajer DS; Wheaton GR; Bullock A; Gentles TL; Weintraub RG; Justo RN; Grigg LE; Radford DJ; Hardikar W; Cheung M; Cain TM; Rao P; Alexander SI; Ayer J; Verrall C; Du Plessis K; Chapman J; Rice K; Barry J; Zannino D; Iyengar AJ;
    Int J Cardiol; 2018 Dec; 273():100-107. PubMed ID: 30060970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatinine-based estimation of glomerular filtration rate in patients with a Fontan circulation.
    Wilson TG; d'Udekem Y; Winlaw DS; Cordina RL; Ayer J; Gentles TL; Weintraub RG; Grigg LE; Cheung M; Cain TM; Rao P; Verrall C; Plessis KD; Rice K; Iyengar AJ
    Congenit Heart Dis; 2019 May; 14(3):454-463. PubMed ID: 30664330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney damage in the adult Fontan population.
    Lee D; Levin A; Kiess M; Sexsmith G; Chakrabarti S; Barlow A; Human D; Grewal J
    Int J Cardiol; 2018 Apr; 257():62-66. PubMed ID: 29506739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients.
    Daems JJN; Attard C; Van Den Helm S; Breur J; D'Udekem Y; du Plessis K; Wilson TG; Winlaw D; Gentles TL; Monagle P; Ignjatovic V
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
    Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
    Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of End-Organ Damage in Fontan Patients Prior to Transition to Adult Care: Are We There Yet?
    Wilson TG; Iyengar AJ; Zentner D; d'Udekem Y
    Heart Lung Circ; 2022 Apr; 31(4):544-548. PubMed ID: 34756660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study.
    Kutty SS; Peng Q; Danford DA; Fletcher SE; Perry D; Talmon GA; Scott C; Kugler JD; Duncan KF; Quiros-Tejeira RE; Kutty S;
    Hepatology; 2014 Jan; 59(1):251-60. PubMed ID: 23913702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dysfunction is associated with higher central venous pressures in patients with Fontan circulation.
    Broda CR; Sriraman H; Wadhwa D; Wang Y; Tunuguntla H; Akcan-Arikan A; Ermis PR; Price JF
    Congenit Heart Dis; 2018 Jul; 13(4):602-607. PubMed ID: 30079627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings.
    Evans WN; Acherman RJ; Ciccolo ML; Carrillo SA; Galindo A; Rothman A; Mayman GA; Adams EA; Reardon LC; Winn BJ; Yumiaco NS; Shimuizu L; Inanaga Y; Deleon RJ; Restrepo H
    Congenit Heart Dis; 2018 Jan; 13(1):38-45. PubMed ID: 29194972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
    Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.
    Ackerman T; Geerts A; Van Vlierberghe H; De Backer J; François K
    Pediatr Cardiol; 2018 Dec; 39(8):1604-1613. PubMed ID: 30032312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry.
    Schilling C; Dalziel K; Nunn R; Du Plessis K; Shi WY; Celermajer D; Winlaw D; Weintraub RG; Grigg LE; Radford DJ; Bullock A; Gentles TL; Wheaton GR; Hornung T; Justo RN; d'Udekem Y
    Int J Cardiol; 2016 Sep; 219():14-9. PubMed ID: 27257850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation.
    Surrey LF; Russo P; Rychik J; Goldberg DJ; Dodds K; O'Byrne ML; Glatz AC; Rand EB; Lin HC
    Hum Pathol; 2016 Nov; 57():106-115. PubMed ID: 27476041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiorgan malfunction after Fontan operation in adult patients].
    Smaś-Suska M; Iwaszczuk P; Róg B; Weryński P; Olszowska M; Podolec P; Tomkiewicz-Pająk L
    Pol Merkur Lekarski; 2017 Oct; 43(256):163-167. PubMed ID: 29084189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
    Friedrich-Rust M; Koch C; Rentzsch A; Sarrazin C; Schwarz P; Herrmann E; Lindinger A; Sarrazin U; Poynard T; Schäfers HJ; Zeuzem S; Abdul-Khaliq H
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):560-7. PubMed ID: 18329470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors.
    Baek JS; Bae EJ; Ko JS; Kim GB; Kwon BS; Lee SY; Noh CI; Park EA; Lee W
    Heart; 2010 Nov; 96(21):1750-5. PubMed ID: 20956491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.
    Fidai A; Dallaire F; Alvarez N; Balon Y; Clegg R; Connelly M; Dicke F; Fruitman D; Harder J; Myers K; Patton DJ; Prieur T; Vorhies E; Myers RP; Martin SR; Greenway SC
    Front Cardiovasc Med; 2017; 4():15. PubMed ID: 28396861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Kidney Function in Survivors Following Fontan Palliation.
    Sharma S; Ruebner RL; Furth SL; Dodds KM; Rychik J; Goldberg DJ
    Congenit Heart Dis; 2016 Dec; 11(6):630-636. PubMed ID: 27106111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.